TC Biopharm (Holdings) Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 1070.7%.

Top 15 shareholders own 2.81% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
1.5%	FNY Investment Advisers, LLC	8,200	US$9.7k	0%	0.01%
0.44%	Bryan Kobel	2,391	US$2.8k	23,800%	no data
0.41%	Citadel Advisors LLC	2,252	US$2.7k	0%	no data
0.22%	Csenge Advisory Group, Llc, Asset Management Arm	1,200	US$1.4k	-17.2%	no data
0.09%	SignatureFD, LLC	492	US$580.6	-17.3%	no data
0.043%	Harbour Investments, Inc.	236	US$278.5	0%	no data
0.038%	UBS Asset Management AG	210	US$247.8	624%	no data
0.037%	New England Capital Financial Advisors LLC	201	US$237.2	0%	no data
0.015%	Rhumbline Advisers Ltd Partnership	84	US$99.1	0%	no data
0.013%	Angela Scott	74	US$87.3	0%	no data
0.012%	Michael Leek	66	US$77.9	0%	no data
0.0022%	Sanctuary Wealth Management, LLC	12	US$14.2	0%	no data
0.00091%	Wells Fargo & Company, Securities and Brokerage Investments	5	US$5.9	0%	no data
0.00018%	Martin Thorp	1	US$1.2	0%	no data
0.00018%	Headlands Technologies Llc, Asset Management Arm	1	US$1.2	-88.9%	no data